Can I, as a psychiatrist, refuse to treat a 53-year-old man who has been on long-term clonazepam (benzodiazepine) and other psychotropic medications for about 20 years if he refuses a taper?

Can You Refuse to Treat a Patient Who Refuses Benzodiazepine Taper?

No, you cannot simply refuse to treat this patient—doing so would constitute patient abandonment, which is explicitly cautioned against in clinical guidelines, even when you and the patient disagree about the necessity of tapering. 1

The Core Ethical and Clinical Framework

The 2022 CDC guidelines on controlled substance management (though focused on opioids, the principles directly apply to benzodiazepines) are unequivocal: when clinicians and patients cannot agree on whether tapering is necessary, you must "acknowledge this discordance, express empathy, and seek to implement treatment changes in a patient-centered manner while avoiding patient abandonment." 1

What This Means in Practice

You have three obligations when a patient refuses to taper:

1. Continue providing care - You cannot terminate the therapeutic relationship solely because the patient refuses your recommendation
2. Engage in shared decision-making - Document your assessment that risks outweigh benefits, but recognize the patient's autonomy
3. Implement harm reduction - If the patient remains on clonazepam, you must optimize their safety while continuing to work toward eventual dose reduction

Your Clinical Algorithm When Taper is Refused

Step 1: Document Your Risk-Benefit Assessment

• After 20 years on clonazepam, this patient faces significant risks: cognitive impairment, falls, respiratory depression (especially with other CNS depressants), tolerance, and protracted dependence 2
• The FDA label explicitly warns that long-term benzodiazepine use leads to physical dependence, and abrupt discontinuation can cause life-threatening withdrawal including seizures 2
• Document that you have explained these risks clearly to the patient

Step 2: Establish Why the Patient is Refusing

• Is it fear of withdrawal symptoms? (anxiety, insomnia, tremor, potential seizures) 2
• Prior failed taper attempts?
• Lack of understanding about gradual vs. abrupt discontinuation?
• Underlying untreated anxiety or panic disorder that needs better management? 2

Step 3: Implement Harm Reduction While Maintaining the Relationship

If the patient absolutely refuses any taper, you must:

• Continue prescribing at the current stable dose rather than abandon the patient 1
• Screen for concurrent substance use, particularly opioids and alcohol, which dramatically increase overdose risk 2
• Optimize non-benzodiazepine treatments for the underlying condition (CBT, SSRIs for panic disorder, sleep hygiene interventions) 3
• Monitor monthly for signs of cognitive decline, falls, misuse, or escalating doses 1
• Educate continuously about risks and benefits, using patient-centered materials like those from the EMPOWER trial, which showed 27% of patients agreed to taper after education alone 3

Step 4: Negotiate Incremental Changes

Even if full discontinuation is refused, work toward:

• Dose stabilization (no increases)
• Very slow, hyperbolic dose reductions (as small as 5-10% per month for long-term users) 4
• Conversion to longer-acting benzodiazepines if on short-acting formulations, which may ease eventual tapering 4
• Adding peer support or psychosocial interventions 4

Critical Pitfalls to Avoid

Do NOT:

• Issue ultimatums ("taper or I won't treat you") - this is patient abandonment 1
• Abruptly discontinue or rapidly reduce the dose without consent - this can cause life-threatening withdrawal seizures 2
• Assume the patient is "drug-seeking" - after 20 years, this is physiologic dependence, not necessarily addiction 2
• Fail to document your ongoing risk-benefit discussions and the patient's informed refusal

DO:

• Frame this as a chronic disease management issue requiring ongoing engagement
• Revisit the taper discussion at every visit with empathy and new information
• Consider consultation with addiction medicine or a psychiatrist experienced in benzodiazepine deprescribing 4
• Recognize that patient agreement is "likely to be a key component of successful tapers" 1

The Legal and Ethical Reality

While you have the right to set boundaries in your practice, refusing to treat a patient solely because they decline a specific intervention (when you can continue to provide safe care) crosses into abandonment territory. 5, 6 The patient retains autonomy to refuse treatment recommendations, even medically sound ones, as long as they have decision-making capacity.

Your path forward: Continue the therapeutic relationship, maintain the current prescription to prevent dangerous withdrawal, persistently educate about risks, optimize alternative treatments, and work incrementally toward dose reduction over months to years. This approach prioritizes patient safety (avoiding withdrawal), maintains the therapeutic alliance, and keeps the door open for future tapering when the patient is ready.